Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 in Metastatic Hormone-Refractory Prostate Cancer
NCT00629525Phase 2Completed
- Start
- Aug 2005
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in prostate cancer (PCa). Started Aug 2005; status: completed.
02
Drugs
everolimus
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00629525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629525.